BioVaxys Lowers Capital-Raise Milestone for DPX™ Acquisition with Horizon
BioVaxys Technology Corp. (CSE: BIOV) has adjusted the terms of its asset acquisition deal with Horizon Technology Finance Corporation, reducing the capital-raise milestone for the DPX™ immune educating platform originally developed by Canadian biotech IMV Inc.
